COMP <GO>
NAGE vs FTLF // PIOTROSKI F-SCORE QUALITY
Niagen Bioscience Inc. (NASDAQ) VS. FitLife Brands Inc. (NASDAQ) • 15-METRIC TALLY: NAGE 8
— FTLF 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: NAGE
LAST: $2.33 (-6.80%) • MKT CAP: $197.8M
piotroski-score
7/9
LAST: $7.84 (-0.88%) • MKT CAP: $74.3M
piotroski-score
6/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NAGE VS. FTLF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NAGE | FTLF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.30% | 43.10% | +21.20 | NAGE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.80% | 5.40% | +11.40 | NAGE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.2x | 24.8x | -12.60 | NAGE | /valuation <GO> |
| Free Cash Flow Yield | 6.83% | 9.96% | -3.13 | FTLF | /fcf-yield <GO> |
| Operating Margin | 12.60% | 18.60% | -6.00 | FTLF | /operating-margins <GO> |
| Net Profit Margin | 13.40% | 39.70% | -26.30 | FTLF | /net-margins <GO> |
| Revenue Growth (YoY) | 29.90% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.40 | 1.24 | +3.16 | NAGE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 6/9 | +1.00 | NAGE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.1 | 31.7 | +11.40 | NAGE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.6x | 10.9x | -1.30 | NAGE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $197.8M | $74.3M | $123.5M | NAGE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NAGE REV | FTLF REV | NAGE GROSS % | FTLF GROSS % | NAGE FCF | FTLF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $129.4M | $15.9M | 64.3% | 43.1% | $13.5M | $7.4M |
| FY 2024 | $99.6M | $64.5M | 61.8% | 43.6% | $12.1M | $9.6M |
| FY 2023 | $83.6M | $0 | — | — | $7.1M | $4.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NAGE // BETA —
FTLF // BETA —